B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. [electronic resource]
Producer: 20100319Description: 327-40 p. digitalISSN:- 1532-0979
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- Burkitt Lymphoma -- classification
- Child
- Drug Resistance, Neoplasm
- Female
- Gene Expression Regulation, Neoplastic
- Gene Rearrangement, B-Lymphocyte, Heavy Chain
- Genes, Immunoglobulin Heavy Chain
- Humans
- Immunophenotyping
- In Situ Hybridization, Fluorescence
- Kaplan-Meier Estimate
- Karyotyping
- Lymphoma, B-Cell -- classification
- Lymphoma, Large B-Cell, Diffuse -- classification
- Male
- Middle Aged
- Neoplasm Staging
- Polymerase Chain Reaction
- Predictive Value of Tests
- Proportional Hazards Models
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Proto-Oncogene Proteins c-myc -- genetics
- Retrospective Studies
- Risk Assessment
- Terminology as Topic
- Time Factors
- Treatment Outcome
- World Health Organization
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.